The positron emission tomography (PET) ligand 68Ga-Glu-urea-Lys(Ahx)-HBED-CC (68Ga-PSMA-11) has dramatically improved diagnostic imaging of prostate cancer. This evidence concerns the gene FOLH1 and prostate carcinoma.